Physician profile
Alicia Pace
NPI 1871145714
$3,010.09
in general payments reported to CMS, 2019-2025
23 companies · $96.58 in 2025
The $96.58 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $630 · 2023: $1,021 · 2024: $896 · 2025: $96.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $843.79 | 2021-2025 | Emblem Mri S-Icd, Ekosonic, Lux-Dx Insertable Cardiac Monitor |
| Bard Peripheral Vascular, INC. | $425.56 | 2022-2025 | Rotarexs 6 F X 135 Cm, Venovo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $285.58 | 2021-2024 | Lifevest |
| Abiomed | $245.11 | 2024 | Impella |
| Shockwave Medical, INC | $237.65 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $191.07 | 2023-2025 | Jeti, Diamondback Peripheral, Xience V |
| Novartis Pharmaceuticals Corporation | $122.97 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $120.74 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.54 | 2021-2024 | Jardiance |
| Cardiva Medical, INC. | $79.04 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $75.50 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $42.52 | 2024 | |
| Biosense Webster, INC. | $33.86 | 2023 | Carto 3 |
| Becton, Dickinson and Company | $29.24 | 2024 | Rotarexs 6 F X 135 Cm |
| Astrazeneca Pharmaceuticals LP | $28.66 | 2021-2023 | Brilinta |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $27.07 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Scpharmaceuticals INC. | $26.65 | 2024 | |
| Lemaitre Vascular, INC. | $20.84 | 2025 | Artegraft Vascular Graft |
| Ethicon US, LLC | $20.00 | 2023 | Stratafix, Dermabond Prineo |
| Bayer Healthcare Pharmaceuticals INC. | $17.79 | 2021 | |
| Terumo Medical Corporation | $17.78 | 2023 | Tr Band, Glidewire |
| Novo Nordisk INC | $15.84 | 2024 | Ozempic, Rybelsus |
| Pfizer INC. | $15.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.